Efficacy and safety of liraglutide compared to sulphonylurea during <scp>R</scp> amadan in patients with type 2 diabetes ( <scp>LIRA‐R</scp> amadan): a randomized trial

Abstract

Despite lower fructosamine levels and body weight at the beginning of Ramadan, use of liraglutide showed similar glycaemic improvements, fewer hypoglycaemic episodes and greater body weight reduction compared with sulphonylurea. LIRA-Ramadan provides evidence for liraglutide being safe and efficacious for management of T2D during Ramadan fasting.